Wednesday 10th March, 2010 | 1:30 pm
Home
|
Sitemap
|
Contact us
Stock Quote
 |
Press Releases
 |
Financial Reports
 |
Electronic IR Package
 |
Site Search:
Stock Quote
Press releases
Financial Reports
Analysts
Webcast
Q4 Announcement
Home
GHRH Phase II Final Results
Fentanyl TAIFUN Phase IIb extension arm results
Q1 Earnings Announcement
Q2 Earnings Announcement
Akela Pharma, name change and corporate update
Media
Electronic IR Package
Contact
Financial Reports
MDA - 2007
Q1
Q4
MDA - 2008
Q1
Q2
Q3
Q4
MDA - 2009
Q2
CFS -
Year ended December 31st, 2006 and 2005
Three-month periods ended March 31st, 2007 and 2006
Three-month periods ended March 31, 2008 and 2007
Three-month periods ended June 30, 2008 and 2007
Three-month periods ended September 30, 2008 and 2007
Three-month periods ended
June 30, 2009 and 2008
Home
::
Our Company
::
Investor Relations
::
Products and Technologies
::
Business Units
::
Contact us
::
Site map
::
FAQ
Copyright 2007 © Akela Pharma